Noninvasive brain stimulation in Alzheimer's disease: Systematic review and perspectives for the future

Experimental Gerontology

Volumn 46, Issue 8, 2011, Pages 611-627

  Freitas, Catarina ^a   Mondragón Llorca, Helena ^a   Pascual Leone, Alvaro ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b University Institute affiliated with the Autonomous University of Barcelona   (Spain)

Author keywords

Alzheimer's disease; Cortical plasticity; Cortical reactivity; Diagnostics; Functional connectivity; Transcranial magnetic stimulation; Treatment

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; GALANTAMINE; LEVODOPA; LEVODOPA METHYL ESTER; PLACEBO; RIVASTIGMINE;

ALZHEIMER DISEASE; BRAIN ATROPHY; CLINICAL TRIAL (TOPIC); COGNITION; DRUG DOSE COMPARISON; ELECTROENCEPHALOGRAM; EVOKED MUSCLE RESPONSE; FACILITATION; HUMAN; INTRACORTICAL INHIBITION; MOTOR CORTEX; MOTOR NERVE CONDUCTION; MOTOR PERFORMANCE; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVOUS SYSTEM PARAMETERS; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RESTING MOTOR THRESHOLD; REVIEW; RISK BENEFIT ANALYSIS; SHORT LATENCY AFFERENT INHIBITION; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; THERAPY EFFECT; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE;

ALZHEIMER DISEASE; CEREBRAL CORTEX; COGNITION; FEMALE; FORECASTING; HUMANS; MALE; NEURONAL PLASTICITY; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 79960074202     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2011.04.001     Document Type: Review

References (126)

1. Alagona G., Bella R., Ferri R., Carnemolla A., Pappalardo A., Costanzo E., et al. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neurosci. Lett. 2001, 314:57-60.
2. Alagona G., Ferri R., Pennisi G., Carnemolla A., Maci T., Domina E., et al. Motor cortex excitability in Alzheimer's disease and in subcortical ischemic vascular dementia. Neurosci. Lett. 2004, 362:95-98.
3. Alberici A., Bonato C., Calabria M., Agosti C., Zanetti O., Miniussi C., et al. The contribution of TMS to frontotemporal dementia variants. Acta Neurol. Scand. 2008, 118:275-280.
4. Alzheimer's Association's Facts and Figures' Report http://www.alz.org/documents_custom/reportalzfactsfigures2010.pdf.
5. Antal A., Chaieb L., Moliadze V., Monte-Silva K., Poreisz C., Thirugnanasambandam N., et al. Brain-derived neurotrophic factor (BDNF) gene polymorphisms shape cortical plasticity in humans. Brain Stimul. 2010, 3:230-237.
6. Bakkour A., Morris J.C., Dickerson B.C. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 2009, 72:1048-1055.
7. Barnes C.A. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 1979, 93:74-104.
8. Barnes C.A. Aging and the physiology of spatial memory. Neurobiol. Aging 1988, 9:563-568.
9. Barnes C.A. Long-term potentiation and the ageing brain. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2003, 358:765-772.
10. Barnes C.A., McNaughton B.L. Physiological compensation for loss of afferent synapses in rat hippocampal granule cells during senescence. J. Physiol. 1980, 309:473-485.
11. Battaglia F., Wang H.Y., Ghilardi M.F., Gashi E., Quartarone A., Friedman E., et al. Cortical plasticity in Alzheimer's disease in humans and rodents. Biol. Psychiatry 2007, 62:1405-1412.
12. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 2007, 39:17-23.
13. Birks J., Grimley Evans J., Iakovidou V., Tsolaki M., Holt F.E. Rivastigmine for Alzheimer's disease. Cochrane Database Syst. Rev. 2009, CD001191.
14. Bliss T.V., Collingridge G.L., Morris R.G. Introduction. Long-term potentiation and structure of the issue. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2003, 358:607-611.
15. Boggio P.S., Khoury L.P., Martins D.C., Martins O.E., de Macedo E.C., Fregni F. Temporal cortex direct current stimulation enhances performance on a visual recognition memory task in Alzheimer disease. J. Neurol. Neurosurg. Psychiatry 2009, 80:444-447.
16. Bouwens S.F., van Heugten C.M., Aalten P., Wolfs C.A., Baarends E.M., van Menxel D.A., et al. Relationship between measures of dementia severity and observation of daily life functioning as measured with the Assessment of Motor and Process Skills (AMPS). Dement. Geriatr. Cogn. Disord. 2008, 25:81-87.
17. Brown R.M., Robertson E.M., Press D.Z. Sequence skill acquisition and off-line learning in normal aging. PLoS One 2009, 4:e6683.
18. Buchman A.S., Boyle P.A., Wilson R.S., Beck T.L., Kelly J.F., Bennett D.A. Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons. Alzheimer Dis. Assoc. Disord. 2009, 23:63-69.
19. Cano S.J., Posner H.B., Moline M.L., Hurt S.W., Swartz J., Hsu T., et al. The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts. J. Neurol. Neurosurg. Psychiatry 2010, 81:1363-1368.
20. Cardenas-Morales L., Nowak D.A., Kammer T., Wolf R.C., Schonfeldt-Lecuona C. Mechanisms and applications of theta-burst rTMS on the human motor cortex. Brain Topogr. 2010, 22:294-306.
21. Cheeran B., Talelli P., Mori F., Koch G., Suppa A., Edwards M., et al. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J. Physiol. 2008, 586:5717-5725.
22. Chen R., Udupa K. Measurement and modulation of plasticity of the motor system in humans using transcranial magnetic stimulation. Motor Control 2009, 13:442-453.
23. Classen J.S.S. Changes in TMS measures induced by repetitive TMS. The Oxford Handbook of Transcranial Stimulation 2008, 185-200. Oxford University Press Inc, New York. Z.U. Wassermann EM, V. Walsh, T. Paus, S. Lisanby (Eds.).
24. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
25. Cotelli M., Manenti R., Cappa S.F., Geroldi C., Zanetti O., Rossini P.M., et al. Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. Arch. Neurol. 2006, 63:1602-1604.
26. Cotelli M., Manenti R., Cappa S.F., Zanetti O., Miniussi C. Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline. Eur. J. Neurol. 2008, 15:1286-1292.
27. Cotelli M., Calabria M., Manenti R., Rosini S., Zanetti O., Cappa S.F., et al. Improved language performance in Alzheimer disease following brain stimulation. J. Neurol. Neurosurg. Psychiatry 2010.
28. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983, 219:1184-1190.
29. Craft S., Teri L., Edland S.D., Kukull W.A., Schellenberg G., McCormick W.C., et al. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 1998, 51:149-153.
30. Crutch S.J., Rossor M.N., Warrington E.K. A novel technique for the quantitative assessment of apraxic deficits: application to individuals with mild cognitive impairment. J. Neuropsychol. 2007, 1:237-257.
31. Cummings J.L., Vinters H.V., Cole G.M., Khachaturian Z.S. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1998, 51:S2-S17. discussion S65-17.
32. Dal Forno G., Rasmusson D.X., Brandt J., Carson K.A., Brookmeyer R., Troncoso J., et al. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch. Neurol. 1996, 53:345-350.
33. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
34. de Carvalho M., de Mendonca A., Miranda P.C., Garcia C., Luis M.L. Magnetic stimulation in Alzheimer's disease. J. Neurol. 1997, 244:304-307.
35. Devanand D.P., Mikhno A., Pelton G.H., Cuasay K., Pradhaban G., Dileep Kumar J.S. Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls. J. Geriatr. Psychiatry Neurol. 2010, 23:185-198.
36. Di Lazzaro V., Oliviero A., Profice P., Pennisi M.A., Di Giovanni S., Zito G., et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp. Brain Res. 2000, 135:455-461.
37. Di Lazzaro V., Oliviero A., Tonali P.A., Marra C., Daniele A., Profice P., et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 2002, 59:392-397.
38. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., et al. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:555-559.
39. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., et al. Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J. Neurol. Neurosurg. Psychiatry 2005, 76:1064-1069.
40. Di Lazzaro V., Pilato F., Dileone M., Saturno E., Oliviero A., Marra C., et al. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 2006, 66:1111-1113.
41. Di Lazzaro V., Pilato F., Dileone M., Saturno E., Profice P., Marra C., et al. Functional evaluation of cerebral cortex in dementia with Lewy bodies. Neuroimage 2007, 37:422-429.
42. Di Lazzaro V., Pilato F., Dileone M., Profice P., Marra C., Ranieri F., et al. In vivo functional evaluation of central cholinergic circuits in vascular dementia. Clin. Neurophysiol. 2008, 119:2494-2500.
43. Dickerson B.C., Eichenbaum H. The episodic memory system: neurocircuitry and disorders. Neuropsychopharmacology 2010, 35:86-104.
44. Dickerson B.C., Bakkour A., Salat D.H., Feczko E., Pacheco J., Greve D.N., et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb. Cortex 2009, 19:497-510.
45. Dollfus S., Larmurier-Montagne A., Razafimandimby A., Allio G., Membrey J.M., Delcroix N., et al. Treatment of auditory hallucinations by combining high-frequency repetitive transcranial magnetic stimulation and functional magnetic resonance imaging. Schizophr. Res. 2008, 102:348-351.
46. Drzezga A., Riemenschneider M., Strassner B., Grimmer T., Peller M., Knoll A., et al. Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology 2005, 64:102-107.
47. Drzezga A., Grimmer T., Henriksen G., Muhlau M., Perneczky R., Miederer I., et al. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology 2009, 72:1487-1494.
48. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
49. Ferreri F., Pauri F., Pasqualetti P., Fini R., Dal Forno G., Rossini P.M. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study. Ann. Neurol. 2003, 53:102-108.
50. Ferrucci R., Mameli F., Guidi I., Mrakic-Sposta S., Vergari M., Marceglia S., et al. Transcranial direct current stimulation improves recognition memory in Alzheimer disease. Neurology 2008, 71:493-498.
51. Forsberg A., Engler H., Almkvist O., Blomquist G., Hagman G., Wall A., et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol. Aging 2008, 29:1456-1465.
52. Growdon J.H., Locascio J.J., Corkin S., Gomez-Isla T., Hyman B.T. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996, 47:444-448.
53. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 2000, 406:147-150.
54. Hallett M. Transcranial magnetic stimulation: a primer. Neuron 2007, 55:187-199.
55. Hashimoto R., Hirata Y., Asada T., Yamashita F., Nemoto K., Mori T., et al. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease. Genes Brain Behav. 2009, 8:43-52.
56. Herholz K. Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease. Expert Rev. Neurother. 2010, 10:1667-1673.
57. Hoogendam J.M., Ramakers G.M., Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul. 2010, 3:95-118.
58. Huang Y.Z., Edwards M.J., Rounis E., Bhatia K.P., Rothwell J.C. Theta burst stimulation of the human motor cortex. Neuron 2005, 45:201-206.
59. Huang Y.Z., Rothwell J.C., Edwards M.J., Chen R.S. Effect of physiological activity on an NMDA-dependent form of cortical plasticity in human. Cereb. Cortex 2008, 18:563-570.
60. Inghilleri M., Conte A., Frasca V., Scaldaferri N., Gilio F., Santini M., et al. Altered response to rTMS in patients with Alzheimer's disease. Clin. Neurophysiol. 2006, 117:103-109.
61. Ives J.R., Rotenberg A., Poma R., Thut G., Pascual-Leone A. Electroencephalographic recording during transcranial magnetic stimulation in humans and animals. Clin. Neurophysiol. 2006, 117:1870-1875.
62. Jing H., Takigawa M. Observation of EEG coherence after repetitive transcranial magnetic stimulation. Clin. Neurophysiol. 2000, 111:1620-1631.
63. Julkunen P., Jauhiainen A.M., Westeren-Punnonen S., Pirinen E., Soininen H., Kononen M., et al. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study. J. Neurosci. Methods 2008, 172:270-276.
64. Kaminski M., Ding M., Truccolo W.A., Bressler S.L. Evaluating causal relations in neural systems: granger causality, directed transfer function and statistical assessment of significance. Biol. Cybern. 2001, 85:145-157.
65. Kelly K.M., Nadon N.L., Morrison J.H., Thibault O., Barnes C.A., Blalock E.M. The neurobiology of aging. Epilepsy Res. 2006, 68(Suppl 1):S5-S20.
66. Kemppainen N.M., Aalto S., Karrasch M., Nagren K., Savisto N., Oikonen V., et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann. Neurol. 2008, 63:112-118.
67. Kleiman T., Zdanys K., Black B., Rightmer T., Grey M., Garman K., et al. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Dement. Geriatr. Cogn. Disord. 2006, 22:73-82.
68. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
69. Kobayashi M., Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol. 2003, 2:145-156.
70. Kramer M.A., Eden U.T., Cash S.S., Kolaczyk E.D. Network inference with confidence from multivariate time series. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 2009, 79:061916.
71. Larson J., Wong D., Lynch G. Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res. 1986, 368:347-350.
72. Li S., Hong S., Shepardson N.E., Walsh D.M., Shankar G.M., Selkoe D. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009, 62:788-801.
73. Liepert J., Bar K.J., Meske U., Weiller C. Motor cortex disinhibition in Alzheimer's disease. Clin. Neurophysiol. 2001, 112:1436-1441.
74. Maeda F., Keenan J.P., Tormos J.M., Topka H., Pascual-Leone A. Interindividual variability of the modulatory effects of repetitive transcranial magnetic stimulation on cortical excitability. Exp. Brain Res. 2000, 133:425-430.
75. Martins C.A., Oulhaj A., de Jager C.A., Williams J.H. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology 2005, 65:1888-1893.
76. Martorana A., Stefani A., Palmieri M.G., Esposito Z., Bernardi G., Sancesario G., et al. l-dopa modulates motor cortex excitability in Alzheimer's disease patients. J. Neural Transm. 2008, 115:1313-1319.
77. Martorana A., Mori F., Esposito Z., Kusayanagi H., Monteleone F., Codeca C., et al. Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. Neuropsychopharmacology 2009, 34:2323-2328.
78. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
79. Miniussi C., Cappa S.F., Cohen L.G., Floel A., Fregni F., Nitsche M.A., et al. Efficacy of repetitive transcranial magnetic stimulation/transcranial direct current stimulation in cognitive neurorehabilitation. Brain Stimul. 2008, 1:326-336.
80. Montagne-Larmurier A., Etard O., Razafimandimby A., Morello R., Dollfus S. Two-day treatment of auditory hallucinations by high frequency rTMS guided by cerebral imaging: a 6month follow-up pilot study. Schizophr. Res. 2009, 113:77-83.
81. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur. J. Nucl. Med. Mol. Imaging 2005, 32:486-510.
82. Mosconi L., Tsui W.H., Herholz K., Pupi A., Drzezga A., Lucignani G., et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J. Nucl. Med. 2008, 49:390-398.
83. Murphy G.M., Taylor J., Kraemer H.C., Yesavage J., Tinklenberg J.R. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. Am. J. Psychiatry 1997, 154:603-608.
84. Nardone R., Bratti A., Tezzon F. Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease. J. Neural Transm. 2006, 113:1679-1684.
85. Nardone R., Bergmann J., Kronbichler M., Kunz A., Klein S., Caleri F., et al. Abnormal short latency afferent inhibition in early Alzheimer's disease: a transcranial magnetic demonstration. J. Neural Transm. 2008, 115:1557-1562.
86. Nitsche M.A., Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J. Physiol. 2000, 527(Pt 3):633-639.
87. Nitsche M.A., Boggio P.S., Fregni F., Pascual-Leone A. Treatment of depression with transcranial direct current stimulation (tDCS): a review. Exp. Neurol. 2009, 219:14-19.
88. Oliviero A., Strens L.H., Di Lazzaro V., Tonali P.A., Brown P. Persistent effects of high frequency repetitive TMS on the coupling between motor areas in the human. Exp. Brain Res. 2003, 149:107-113.
89. O'Reardon J.P., Solvason H.B., Janicak P.G., Sampson S., Isenberg K.E., Nahas Z., et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol. Psychiatry 2007, 62:1208-1216.
90. Pascual-Leone A., Tormos J.M., Keenan J., Tarazona F., Canete C., Catala M.D. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J. Clin. Neurophysiol. 1998, 15:333-343.
91. Paulus W., Classen J., Cohen L.G., Large C.H., Di Lazzaro V., Nitsche M., et al. State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimul. 2008, 1:151-163.
92. Pennisi G., Alagona G., Ferri R., Greco S., Santonocito D., Pappalardo A., et al. Motor cortex excitability in Alzheimer disease: one year follow-up study. Neurosci. Lett. 2002, 329:293-296.
93. Pepin J.L., Bogacz D., de Pasqua V., Delwaide P.J. Motor cortex inhibition is not impaired in patients with Alzheimer's disease: evidence from paired transcranial magnetic stimulation. J. Neurol. Sci. 1999, 170:119-123.
94. Perretti A., Grossi D., Fragassi N., Lanzillo B., Nolano M., Pisacreta A.I., et al. Evaluation of the motor cortex by magnetic stimulation in patients with Alzheimer disease. J. Neurol. Sci. 1996, 135:31-37.
95. Pierantozzi M., Panella M., Palmieri M.G., Koch G., Giordano A., Marciani M.G., et al. Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia. Clin. Neurophysiol. 2004, 115:2410-2418.
96. Pivac N., Nikolac M., Nedic G., Mustapic M., Borovecki F., Hajnsek S., et al. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010.
97. Rabinovici G.D., Roberson E.D. Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease. Ann. Neurol. 2010, 67:283-285.
98. Roman F., Staubli U., Lynch G. Evidence for synaptic potentiation in a cortical network during learning. Brain Res. 1987, 418:221-226.
99. Rosen W.G., Mohs R.C., Davis K.L. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 1984, 141:1356-1364.
100. Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol. 2009, 120:2008-2039.
101. Rowe C.C., Ng S., Ackermann U., Gong S.J., Pike K., Savage G., et al. Imaging beta-amyloid burden in aging and dementia. Neurology 2007, 68:1718-1725.
102. Sakuma K., Murakami T., Nakashima K. Short latency afferent inhibition is not impaired in mild cognitive impairment. Clin. Neurophysiol. 2007, 118:1460-1463.
103. Sameshima K., Baccala L.A. Using partial directed coherence to describe neuronal ensemble interactions. J. Neurosci. Methods 1999, 94:93-103.
104. Sando S.B., Melquist S., Cannon A., Hutton M.L., Sletvold O., Saltvedt I., et al. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC Neurol. 2008, 8:9.
105. Schindler K., Nyffeler T., Wiest R., Hauf M., Mathis J., Hess Ch W., et al. Theta burst transcranial magnetic stimulation is associated with increased EEG synchronization in the stimulated relative to unstimulated cerebral hemisphere. Neurosci. Lett. 2008, 436:31-34.
106. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008, 14:837-842.
107. Silvanto J., Pascual-Leone A. State-dependency of transcranial magnetic stimulation. Brain Topogr. 2008, 21:1-10.
108. Slotema C.W., Blom J.D., Hoek H.W., Sommer I.E. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J. Clin. Psychiatry 2010, 71:873-884.
109. Sparing R., Mottaghy F.M. Noninvasive brain stimulation with transcranial magnetic or direct current stimulation (TMS/tDCS)-from insights into human memory to therapy of its dysfunction. Methods 2008, 44:329-337.
110. Stagg C.J., Nitsche M.A. Physiological basis of transcranial direct current stimulation. Neuroscientist 2011, 17:37-53.
111. Stefan K., Kunesch E., Cohen L.G., Benecke R., Classen J. Induction of plasticity in the human motor cortex by paired associative stimulation. Brain 2000, 123(Pt 3):572-584.
112. Strens L.H., Oliviero A., Bloem B.R., Gerschlager W., Rothwell J.C., Brown P. The effects of subthreshold 1Hz repetitive TMS on cortico-cortical and interhemispheric coherence. Clin. Neurophysiol. 2002, 113:1279-1285.
113. Thut G., Pascual-Leone A. Integrating TMS with EEG: how and what for?. Brain Topogr. 2010, 22:215-218.
114. Thut G., Pascual-Leone A. A review of combined TMS-EEG studies to characterize lasting effects of repetitive TMS and assess their usefulness in cognitive and clinical neuroscience. Brain Topogr. 2010, 22:219-232.
115. Thut G., Ives J.R., Kampmann F., Pastor M.A., Pascual-Leone A. A new device and protocol for combining TMS and online recordings of EEG and evoked potentials. J. Neurosci. Methods 2005, 141:207-217.
116. Tiraboschi P., Hansen L.A., Masliah E., Alford M., Thal L.J., Corey-Bloom J. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 2004, 62:1977-1983.
117. Tokimura H., Di Lazzaro V., Tokimura Y., Oliviero A., Profice P., Insola A., et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J. Physiol. 2000, 523(Pt 2):503-513.
118. Wagner T., Gangitano M., Romero R., Theoret H., Kobayashi M., Anschel D., et al. Intracranial measurement of current densities induced by transcranial magnetic stimulation in the human brain. Neurosci. Lett. 2004, 354:91-94.
119. Wagner T., Valero-Cabre A., Pascual-Leone A. Noninvasive human brain stimulation. Annu. Rev. Biomed. Eng. 2007, 9:527-565.
120. Wagner T., Eden U., Fregni F., Valero-Cabre A., Ramos-Estebanez C., Pronio-Stelluto V., et al. Transcranial magnetic stimulation and brain atrophy: a computer-based human brain model study. Exp. Brain Res. 2008, 186:539-550.
121. Weintraub S., Salmon D., Mercaldo N., Ferris S., Graff-Radford N.R., Chui H., et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis. Assoc. Disord. 2009, 23:91-101.
122. Wolk D.A., Dickerson B.C. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc. Natl Acad. Sci. U. S. A. 2010, 107:10256-10261.
123. Wolk D.A., Price J.C., Saxton J.A., Snitz B.E., James J.A., Lopez O.L., et al. Amyloid imaging in mild cognitive impairment subtypes. Ann. Neurol. 2009, 65:557-568.
124. Wolters A., Sandbrink F., Schlottmann A., Kunesch E., Stefan K., Cohen L.G., et al. A temporally asymmetric Hebbian rule governing plasticity in the human motor cortex. J. Neurophysiol. 2003, 89:2339-2345.
125. Ziemann U. Pharmacology of TMS measures. The Oxford Handbook of Transcranial Stimulation 2008, 135-151. Oxford University Press Inc, New York. Z.U. Wassermann EM, V. Walsh, T. Paus, S. Lisanby (Eds.).
126. Ziemann U., Paulus W., Nitsche M.A., Pascual-Leone A., Byblow W.D., Berardelli A., et al. Consensus: Motor cortex plasticity protocols. Brain Stimul. 2008, 1:164-182.